Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by regionAll jurisdictions
What for?
by area of lawAll areas of law
Who?
by company- Becton, Dickinson and Company (BD) €166.7m 51 % · 1 case
- Access DX Laboratory, LLC €31.7m 10 % · 1 case
- DaVita Inc. €31.6m 10 % · 1 case
- Advanced Pathology Solutions PLLC und APS MSO LLC €25.9m 8 % · 1 case
- Medirex s. r. o.; KLINICKÁ BIOCHÉMIA s.r.o.; Unilabs Slovensko, s. r. o.; synlab slovakia s. r. o.; Asociácia laboratórií €14.6m 4 % · 1 case
- Innovasis Inc. €11.1m 3 % · 1 case
- NeoGenomics Laboratories Inc. €8.59m 3 % · 1 case
- PHOENIX Zdravotnícke zásobovanie, a.s.; TRANSMEDIC SLOVAKIA, s.r.o. (in Konkurs) €7.8m 2 % · 1 case
- Modern Nuclear Inc. €7.12m 2 % · 1 case
- New York-Presbyterian Hudson Valley Hospital €5.79m 2 % · 1 case
- 26 more€18m
When?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 0 | — |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 0 | — |
| Q1 2025 | 0 | — |
| Q2 2025 | 0 | — |
| Q3 2025 | 0 | — |
| Q4 2025 | 1 | €128,557 |
| Q1 2026 | 0 | — |
| Q2 2026 | 0 | — |
| Q3 2026 | 0 | — |
1 case
3 Dec 2025 Southern Health Solutions, Inc. (Next Medical / NextMed)NextMed: FTC settlement over allegations of hidden costs and review manipulation €128,557
According to the FTC, the telemedicine company advertised GLP-1 weight-loss programmes with monthly prices that did not include medication, laboratory costs and medical consultations, concealed the minimum term and cancellation fees, published fake testimonials from employees and relatives, and induced customers to delete negative reviews by offering vouchers or refunds. Under the final settlement order, the company and its management are paying 150,000 USD, which is earmarked for refunds.
"Buying off" negative reviews with vouchers is just as misleading as inventing positive ones.
Review manipulation and price disclosures
- Authority / court
- Federal Trade Commission (FTC)
- Area of law
- Consumer protection and online retail · Fake reviews
- Legal basis
- Section 5 FTC Act; Restore Online Shoppers' Confidence Act (ROSCA)
- Action
- Disgorgement of profits
- Status of proceedings
- final
- Sector
- Healthcare
- Liability of senior managers
- Founder Robert Epstein and CEO Frank Leonardo III are named in the press release as parties involved.
- Published
- 3 Dec 2025
Original amount 150,000 USD, converted at the ECB reference rate of 3 Dec 2025.
- FTC Takes Action Against Telemedicine Firm NextMed Press release of an authority
- FTC Approves Final Order against Telehealth Provider NextMed (03.12.2025) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link